PlainRecalls
FDA Drug Moderate Class II Ongoing

Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister)

Reported: June 11, 2025 Initiated: May 27, 2025 #D-0456-2025

Product Description

Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister)

Reason for Recall

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Details

Recalling Firm
Torrent Pharma Inc.
Units Affected
972 Cartons
Distribution
U.S. Nationwide.
Location
Basking Ridge, NJ

Frequently Asked Questions

What product was recalled?
Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister). Recalled by Torrent Pharma Inc.. Units affected: 972 Cartons.
Why was this product recalled?
CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 11, 2025. Severity: Moderate. Recall number: D-0456-2025.